This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Down -6.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Imax (IMAX)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Imax (IMAX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
IMAX vs. WMG: Which Stock Is the Better Value Option?
by Zacks Equity Research
IMAX vs. WMG: Which Stock Is the Better Value Option?
IMAX Q3 Earnings Beat, Revenues Rise Y/Y on Box Office Gain
by Zacks Equity Research
IMAX's third-quarter 2023 results reflect growth in revenues and the global box office, driven by the impressive performance of blockbuster titles.
Imax (IMAX) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Imax (IMAX) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Imax (IMAX) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Imax (IMAX) delivered earnings and revenue surprises of 66.67% and 6.93%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
IMAX and Hengdian Films Expand in China With 20 New Locations
by Zacks Equity Research
IMAX announces extending its collaboration with Hengdian Films to establish 20 new IMAX locations in China.
Imax (IMAX) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Imax (IMAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Whirlpool (WHR) Beat Q3 Earnings Countering Inflation?
by Zacks Equity Research
Whirlpool (WHR) Q3 results are expected to have gained from decisive actions to protect margins and productivity amid the ongoing supply-chain constraints and significant inflationary pressures.
IMAX Partners With NCG Cinemas for 3 Locations in the US
by Zacks Equity Research
IMAX expands partnership with NCG Cinemas to open three IMAX with Laser Systems in the United States.
Zacks Industry Outlook Highlights Warner Music, News, Lions Gate and IMAX
by Zacks Equity Research
Warner Music, News, Lions Gate and IMAX have been highlighted in this Industry Outlook article.
IMAX Starts Selling Tickets for Renaissance: A Film by Beyonce
by Zacks Equity Research
IMAX announces that it has made tickets available for Renaissance: A Film by Beyonce at selected locations only.
4 Stocks to Watch From a Prospering Entertainment Industry
by Vasundhara Sawalka
Film and television production and distribution companies like WMG, NWSA, LGF.A and IMAX are benefiting from higher consumption of digital entertainment and a recovering ad spending environment.
Paramount Global (PARA), CBS Sports to Elevate Social Initiative
by Zacks Equity Research
Paramount Global's (PARA) Content for Change and CBS Sports team up on a series of short-form vignettes, which will highlight the social impacts of NFL players and teams.
Warner Bros. Discovery (WBD) Sports UK Rides on Cycling Coverage
by Zacks Equity Research
Warner Bros. Discovery (WBD) Sports Europe reports record-breaking streaming figures following its coverage of Grand Tours, such as Giro d'Italia, Tour de France and La Vuelta.
Lions Gate (LGF.A) Moves 5.2% Higher: Will This Strength Last?
by Zacks Equity Research
Lions Gate (LGF.A) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
IMAX to Present Its New Stream Smart Technology at IBC 2023
by Zacks Equity Research
IMAX is set to showcase its next-generation streaming technology, Stream Smart, at IBC 2023, as part of its strategy for expanding the adoption of the global technology platform.
WWE (WWE) Down 8.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
WWE (WWE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Imax (IMAX) Down 1.1% Since Last Earnings Report?
by Zacks Equity Research
Imax (IMAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ETFs & Stocks in Focus on "Barbie"s Billion-Dollar Success
by Sanghamitra Saha
As "Barbie" continues to shine at the box office, investors may want to closely monitor ETFs that align with the themes and industries influenced by this groundbreaking cinematic achievement.
IMAX Shares Jump on Q2 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
IMAX's second-quarter 2023 results reflect growth in revenues and global box office, driven by impressive performance of blockbuster titles.
Here's What Key Metrics Tell Us About Imax (IMAX) Q2 Earnings
by Zacks Equity Research
Although the revenue and EPS for Imax (IMAX) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Imax (IMAX) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Imax (IMAX) delivered earnings and revenue surprises of 52.94% and 10.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
IMAX's Oppenheimer Breaks Records With $35 Million Global Debut
by Zacks Equity Research
IMAX achieves a record-shattering weekend at the global box office because of the phenomenal $35 million debut of Oppenheimer.
Media Stocks & ETFs in Focus on "Barbenheimer"s Success
by Sanghamitra Saha
The box office is buzzing with excitement as Warner Bros.' "Barbie" and Universal's "Oppenheimer" took center stage during the much-anticipated "Barbenheimer" weekend.
Imax (IMAX) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Imax (IMAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.